Table of Contents
Losartan is an angiotensin II receptor blocker (ARB) commonly prescribed for hypertension and diabetic nephropathy. Its dosing requires careful consideration, especially in patients with renal impairment, to prevent adverse effects and ensure therapeutic efficacy.
Understanding Renal Impairment and Losartan
Renal impairment affects the kidneys’ ability to filter waste and maintain fluid and electrolyte balance. When prescribing losartan to these patients, clinicians must consider altered pharmacokinetics and increased risk of hyperkalemia and hypotension.
Initial Dosing Recommendations
For patients with mild to moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2), the initial dose of losartan is typically 50 mg once daily. In cases of severe impairment (eGFR < 30 mL/min/1.73 m2), starting doses should be reduced to 25 mg once daily or less.
Adjusting Dosage Based on Response and Tolerance
Monitoring blood pressure, serum potassium, and renal function is essential after initiating therapy. If the desired blood pressure reduction is not achieved, the dose can be titrated up to a maximum of 100 mg daily, divided into one or two doses, depending on patient response and tolerability.
Special Considerations
In patients with significant renal impairment or those on concomitant medications that affect renal function (e.g., diuretics, NSAIDs), the risk of adverse effects increases. Close monitoring is advised, and dose adjustments should be made cautiously.
Summary of Dosing Strategy
- Start with 25-50 mg once daily based on renal function
- Monitor renal function and serum potassium within 1-2 weeks of initiation
- Adjust dose gradually, up to 100 mg daily as tolerated
- Reassess regularly, especially in severe renal impairment
Implementing appropriate dosing strategies for losartan in patients with renal impairment is vital to optimize outcomes and minimize risks. Individualized treatment plans and vigilant monitoring are key components of safe therapy.